Accessibility Menu
 
Monash IVF Group logo

Monash IVF Group

(ASX) MVF

Current Price$0.67
Market Cap$259.11M
Since IPO (2014)-39%
5 Year-23%
1 Year-38%
1 Month+4%

Monash IVF Group Financials at a Glance

Market Cap

$259.11M

Revenue (TTM)

$539.30M

Net Income (TTM)

$12.87M

EPS (TTM)

$0.04

P/E Ratio

17.10

Dividend

$0.01

Beta (Volatility)

0.04 (Low)

Price

$0.67

Volume

378,914

Open

$0.67

Previous Close

$0.67

Daily Range

$0.66 - $0.68

52-Week Range

$0.54 - $0.90

MVF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Monash IVF Group

Industry

Healthcare Providers and Services

Employees

892

CEO

Malik Jainudeen

Headquarters

Richmond, VIC 3121, AU

MVF Financials

Key Financial Metrics (TTM)

Gross Margin

28%

Operating Margin

11%

Net Income Margin

6%

Return on Equity

6%

Return on Capital

7%

Return on Assets

3%

Earnings Yield

5.85%

Dividend Yield

0.02%

Payout Ratio

66.83%

Stock Overview

Market Cap

$259.11M

Shares Outstanding

389.63M

Volume

378.91K

Short Interest

0.00%

Avg. Volume

697.01K

Financials (TTM)

Gross Profit

$90.31M

Operating Income

$43.41M

EBITDA

$53.01M

Operating Cash Flow

$12.90M

Capital Expenditure

$12.43M

Free Cash Flow

$468.00K

Cash & ST Invst.

$9.43M

Total Debt

$180.31M

Monash IVF Group Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$137.86M

+9.7%

Gross Profit

$33.34M

-11.9%

Gross Margin

24.19%

N/A

Market Cap

$259.11M

N/A

Market Cap/Employee

$259.89K

N/A

Employees

997

N/A

Net Income

$7.16M

-43.9%

EBITDA

$27.05M

-9.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$273.67M

-136.3%

Accounts Receivable

$25.45M

+26.4%

Inventory

$10.36M

+57.7%

Long Term Debt

$270.85M

+276.1%

Short Term Debt

$10.97M

-78.0%

Return on Assets

2.97%

N/A

Return on Invested Capital

6.69%

N/A

Free Cash Flow

$3.14M

-73.3%

Operating Cash Flow

$13.13M

-46.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TTX.AXTetratherix Ltd.
$4.94+5.11%
AVR.AXAnteris Technologies Ltd
$7.59+1.07%
AFP.AXAFT Pharmaceuticals Limited
$2.85+0.00%
DXB.AXDimerix Limited
$0.34-5.56%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.45+0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$48.96+0.02%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$67.86-0.02%
NIONio
$6.07-0.05%

Questions About MVF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.